Completed OBSERVATIONAL NCT06879795

Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels

Effect of Systemic Retinoic Acid Use on Periodontium-Related T Cell Differentiation

Sponsor: Medipol University

Conditions Acne Vulgaris Gingivitis and Periodontal Diseases Inflammation Biomarkers Saliva Collection Vitamin A

Updated 3 times since 2025 Last updated: Mar 14, 2025 Started: Sep 1, 2023 Primary completion: Jul 1, 2024 Completion: Jul 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acne Vulgaris and Gingivitis and Periodontal Diseases and is currently completed. Medipol University leads this study, which shows 3 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2025 — Present [monthly]

Completed
Jun 2025 — Sep 2025 [monthly]

Completed
Apr 2025 — Jun 2025 [monthly]

Completed

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medipol University

Data source: Medipol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)